Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2658 to 2707 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin alpha chain, brain (spectrin, non-erythroid alpha chain) (alpha-ii spectrin) (fodrin alpha chain). [source:swissprot;acc:q13813]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3038\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin beta chain, brain 1 (spectrin, non-erythroid beta chain 1) (beta-ii spectrin) (fodrin beta chain). [source:swissprot;acc:q01082]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1602\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5232.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5605.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07142\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin beta chain, brain 2 (spectrin, non-erythroid beta chain 2) (beta-iii spectrin). [source:swissprot;acc:o15020]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1601\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
968\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1334\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5804.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6270.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08018\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sperm tail protein shippo1; h-shippo 1. [source:refseq;acc:nm\_053280]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2797\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
69\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spermidine synthase (ec 2.5.1.16) (putrescine aminopropyltransferase) (spdsy). [source:swissprot;acc:p19623]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1306\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5500.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5949.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0815\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spermine synthase (ec 2.5.1.22) (spermidine aminopropyltransferase) (spmsy). [source:swissprot;acc:p52788]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3118\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1238\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5873.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6370.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08457\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
339.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingosine kinase 1 (ec 2.7.1.-) (sk 1) (spk 1). [source:swissprot;acc:q9nya1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
472\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
485\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sphingosine-1-phosphate lyase 1; sphingosine-1-phosphate lyase. [source:refseq;acc:nm\_003901]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1468\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5473.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5887.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07571\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spir-2 protein (fragment). [source:sptrembl;acc:q8wwl2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2879\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spliceosomal u5 snrnp-specific 15 kda protein (dim1 protein homolog) (thioredoxin-like u5 snrnp protein u5-15kd). [source:swissprot;acc:o14834]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
236\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4723.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5828.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing coactivator subunit srm300; rna binding protein; at-rich element binding factor. [source:refseq;acc:nm\_016333]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1958\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5448.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5777.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06039\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3 subunit 1 (spliceosome associated protein 114) (sap 114) (sf3a120). [source:swissprot;acc:q15459]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
649\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5248.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5901.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3a subunit 2 (spliceosome associated protein 62) (sap 62) (sf3a66). [source:swissprot;acc:q15428]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
296\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4911.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5909.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3a subunit 3 (spliceosome associated protein 61) (sap 61) (sf3a60). [source:swissprot;acc:q12874]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
648\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5248.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5901.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
191\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4638.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5923.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.27712\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3b subunit 2 (spliceosome associated protein 145) (sap 145) (sf3b150) (pre-mrna splicing factor sf3b 145 kda subunit). [source:swissprot;acc:q13435]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
348\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4991.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
207\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4771.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5961.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24946\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 3b subunit 4 (spliceosome associated protein 49) (sap 49) (sf3b50) (pre-mrna splicing factor sf3b 49 kda subunit). [source:swissprot;acc:q15427]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1224\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4331.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4700.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
395\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4532.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5269.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16251\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor arginine/serine-rich 11 (arginine-rich 54 kda nuclear protein) (p54). [source:swissprot;acc:q05519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1976\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5939.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6294.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor u2af 35 kda subunit (u2 auxiliary factor 35 kda subunit) (u2 snrnp auxiliary factor small subunit). [source:swissprot;acc:q01081]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1959\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5448.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5777.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06039\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor u2af 65 kda subunit (u2 auxiliary factor 65 kda subunit) (u2 snrnp auxiliary factor large subunit) (hu2af(65)). [source:swissprot;acc:p26368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1961\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 1 (pre-mrna splicing factor sf2, p33 subunit) (alternative splicing factor asf-1). [source:swissprot;acc:q07955]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2549\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4725.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4824.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
889\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5903.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6506.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 8 (suppressor of white apricot protein homolog). [source:swissprot;acc:q12872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2267\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9146.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8743.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04599\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
splicing factor, proline-and glutamine-rich (polypyrimidine tract- binding protein-associated splicing factor) (ptb-associated splicing factor) (psf) (dna-binding p52/p100 complex, 100 kda subunit). [source:swissprot;acc:p23246]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2070\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10178.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9638.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sporulation-induced transcript 4-associated protein. [source:refseq;acc:nm\_018312]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1512\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7234.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7771.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
676\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
677\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
675\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
674\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
spry domain-containing socs box protein ssb-1. [source:refseq;acc:nm\_025106]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2814\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
spry domain-containing socs box protein ssb-4. [source:refseq;acc:nm\_080862]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2806\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
squalene monooxygenase (ec 1.14.99.7) (squalene epoxidase) (se). [source:swissprot;acc:q14534]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2166\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6952.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7315.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5767.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6165.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06904\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
310\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4909.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5878.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19736\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sqv-7-like protein (fragment). [source:sptrembl;acc:o95454]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2222\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5309.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5066.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04793\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sr rich protein. [source:refseq;acc:nm\_032870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6245.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6534.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04626\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ss18-like protein 1 (syt homolog-1). [source:swissprot;acc:o75177]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2766\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ssxt protein (synovial sarcoma, translocated to x chromosome) (syt protein). [source:swissprot;acc:q15532]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2942\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
478\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
star-related lipid transfer protein 4 (stard4) (start domain- containing protein 4). [source:swissprot;acc:q96dr4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1870\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
star-related lipid transfer protein 5 (stard5) (start domain- containing protein 5). [source:swissprot;acc:q9nsy2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1865\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
star-related lipid transfer protein 6 (stard6) (start domain- containing protein 6). [source:swissprot;acc:p59095]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1862\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/